Is there need for radioimmunotherapy? results of a phase I/II study in patients with indolent B-cell lymphomas using lutetium-177-DOTA-rituximab
Forrer F, Oechslin-Oberholzer C, Campana B, Maecke H, Mueller-Brand J, Lohri A. Is there need for radioimmunotherapy? results of a phase I/II study in patients with indolent B-cell lymphomas using lutetium-177-DOTA-rituximab. Q J Nucl Med Mol Imaging 2012; 56:544-50.
01.12.2012
Is there need for radioimmunotherapy? results of a phase I/II study in patients with indolent B-cell lymphomas using lutetium-177-DOTA-rituximab
01.12.2012
Q J Nucl Med Mol Imaging 2012; 56:544-50
Forrer Flavio, Oechslin-Oberholzer C, Campana B, Maecke H, Mueller-Brand J, Lohri A
Weiter
